Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ST6GAL1 | P15907 | 18/20 | 1.00 |
| ▸ | ST3GAL1 | Q11201 | 2/20 | 0.83 |
| ▸ | ST3GAL3 | Q11203 | 1/20 | 0.83 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18576098 | 1.00 | ST6GAL1 (1.00) | ST6GAL1ST3GAL1ST3GAL3 | |
| SCHEMBL20480772 | 1.00 | ST6GAL1 (1.00) | ST6GAL1ST3GAL1ST3GAL3 | |
| SCHEMBL20480697 | 0.97 | ST6GAL1 (1.00) | ST6GAL1ST3GAL1ST3GAL3 | |
| SCHEMBL20479982 | 0.97 | ST6GAL1 (1.00) | ST6GAL1ST3GAL1ST3GAL3 | |
| SCHEMBL18575716 | 0.97 | ST6GAL1 (1.00) | ST6GAL1ST3GAL1ST3GAL3 | |
| SCHEMBL20479979 | 0.97 | ST6GAL1 (1.00) | ST6GAL1ST3GAL1ST3GAL3 | |
| SCHEMBL20479985 | 0.97 | ST6GAL1 (1.00) | ST6GAL1ST3GAL1ST3GAL3 | |
| SCHEMBL20480252 | 0.97 | ST6GAL1 (1.00) | ST6GAL1ST3GAL1ST3GAL3 | |
| SCHEMBL20480694 | 0.97 | ST6GAL1 (1.00) | ST6GAL1ST3GAL1ST3GAL3 | |
| SCHEMBL18575946 | 0.97 | ST6GAL1 (1.00) | ST6GAL1ST3GAL1ST3GAL3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10889611-B2 | Sialyltransferase inhibitors and uses thereof | ACADEMIA SINICA (TW) | 2021-01-12 | — | — | US | disclosed |
| US-20180244713-A1 | SIALYLTRANSFERASE INHIBITORS AND USES THEREOF | ACADEMIA SINICA (TW) | 2018-08-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10889611-B2 | Sialyltransferase inhibitors and uses thereof | ST6GAL1, NEU1, GALNT1 | ST6GAL1 1/4885ST3GAL1 16/4885ST3GAL3 21/4885 |
| US-20180244713-A1 | SIALYLTRANSFERASE INHIBITORS AND USES THEREOF | ST6GAL1, NEU1, GALNT1 | ST6GAL1 1/4885ST3GAL1 16/4885ST3GAL3 21/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.